Biomarin Pharmaceutical Inc SEC filings BMRN
Biomarin Pharmaceutical Inc has 1,000 filings in SEC EDGAR's recent list, going back to Feb 2, 2017. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SC TO-T/A | Filing | Jul 1, 2025 | — |
| SC TO-T/A | Filing | Jun 17, 2025 | — |
| CORRESP | Letter to the SEC | Jun 13, 2025 | — |
| SC TO-T/A | Filing | Jun 13, 2025 | — |
| SC TO-T/A | Filing | Jun 4, 2025 | — |
| SC TO-T | Filing | Jun 2, 2025 | — |
| SC TO-C | Filing | May 19, 2025 | — |
| SC TO-C | Filing | May 19, 2025 | — |
| SC TO-C | Filing | May 16, 2025 | — |
| SC TO-C | Filing | May 16, 2025 | — |
| UPLOAD | Letter from the SEC | Oct 3, 2024 | — |
| CORRESP | Letter to the SEC | Sep 16, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 2, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2023 | — |
| CORRESP | Letter to the SEC | Apr 6, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 29, 2022 | — |
| CORRESP | Letter to the SEC | Feb 23, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 31, 2022 | — |
| CORRESP | Letter to the SEC | Dec 20, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 7, 2021 | — |
| CT ORDER | Filing | Feb 12, 2018 | — |
| CT ORDER | Filing | Nov 17, 2017 | — |
| 305B2 | Filing | Aug 8, 2017 | — |
| UPLOAD | Letter from the SEC | May 25, 2017 | — |
| CORRESP | Letter to the SEC | May 2, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2017 | — |
| CT ORDER | Filing | Apr 6, 2017 | — |
| CT ORDER | Filing | Apr 5, 2017 | — |
Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BMRN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Novato, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1048477
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.